Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,39 USD | +3,91% | +5,29% | +35,03% |
09/04 | TAYSHA GENE THERAPIES, INC. : Piper Sandler ontvangt een koopadvies | ZM |
21/03 | TAYSHA GENE THERAPIES, INC. : Chardan Research handhaaft koopadvies | ZM |
Omzet 2024 * | 9,22 mln. 8,62 mln. | Omzet 2025 * | 5,09 mln. 4,76 mln. | Marktkapitalisatie | 447 mln. 418 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -77 mln. -72,02 mln. | Nettowinst (verlies) 2025 * | -92 mln. -86,04 mln. | EV/omzet 2024 * | 37,4 x |
Nettoliquiditeiten 2024 * | 102 mln. 95,71 mln. | Nettoliquiditeiten 2025 * | 144 mln. 134 mln. | EV/omzet 2025 * | 59,6 x |
K/w-verhouding 2024 * |
-5,89
x | K/w-verhouding 2025 * |
-5,03
x | Werknemers | 52 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 75,23% |
Recentste transcriptie over Taysha Gene Therapies, Inc.
1 dag | +3,91% | ||
1 week | +5,29% | ||
Lopende maand | -16,72% | ||
1 maand | -24,61% | ||
3 maanden | +61,49% | ||
6 maanden | +7,90% | ||
Lopend jaar | +35,03% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Nolan
CEO | Chief Executive Officer | 56 | 01-03-20 |
Kamran Alam
DFI | Director of Finance/CFO | 46 | 01-08-20 |
President | 58 | 01-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Philip Donenberg
BRD | Director/Board Member | 63 | 31-08-20 |
Sean Nolan
CEO | Chief Executive Officer | 56 | 01-03-20 |
Sean Stalfort
BRD | Director/Board Member | 54 | 21-06-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 2,39 | +3,91% | 890 189 |
25-04-24 | 2,3 | -2,13% | 1 560 849 |
24-04-24 | 2,35 | -7,11% | 794 093 |
23-04-24 | 2,53 | +2,85% | 1 459 037 |
22-04-24 | 2,46 | +8,37% | 1 459 716 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,03% | 447 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |